GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan
· Delayed Price · Currency is PKR 356.56
-6.79 (-1.87%)
At close: Apr 28, 2026
GlaxoSmithKline Pakistan Balance Sheet
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 8,592 | 6,513 | 3,611 | 4,755 | 7,085 | Upgrade
|
| Short-Term Investments | - | - | - | - | 1,633 | Upgrade
|
| Cash & Short-Term Investments | 8,592 | 6,513 | 3,611 | 4,755 | 8,719 | Upgrade
|
| Cash Growth | 31.91% | 80.39% | -24.06% | -45.47% | 43.98% | Upgrade
|
| Accounts Receivable | 2,813 | 555.14 | 1,028 | 1,585 | 1,316 | Upgrade
|
| Other Receivables | 8,991 | 10,337 | 7,506 | 5,582 | 1,669 | Upgrade
|
| Receivables | 11,858 | 10,947 | 8,587 | 7,217 | 3,043 | Upgrade
|
| Inventory | 13,068 | 11,447 | 11,794 | 9,726 | 6,696 | Upgrade
|
| Prepaid Expenses | 185.98 | 181.1 | 190.75 | 123 | 7.21 | Upgrade
|
| Other Current Assets | 1,452 | 1,610 | 1,158 | 1,682 | 503.93 | Upgrade
|
| Total Current Assets | 35,156 | 30,698 | 25,341 | 23,503 | 18,969 | Upgrade
|
| Property, Plant & Equipment | 14,433 | 13,262 | 11,701 | 10,997 | 10,408 | Upgrade
|
| Goodwill | 955.74 | 955.74 | 955.74 | 955.74 | 955.74 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 36 | Upgrade
|
| Other Long-Term Assets | 50.15 | 50.15 | 50.15 | 27.52 | 22.01 | Upgrade
|
| Total Assets | 50,684 | 45,055 | 38,131 | 35,542 | 30,455 | Upgrade
|
| Accounts Payable | 1,308 | 1,089 | 1,616 | 560.52 | 652.17 | Upgrade
|
| Accrued Expenses | 8,074 | 7,147 | 5,404 | 4,098 | 3,776 | Upgrade
|
| Short-Term Debt | 246.51 | 198.63 | 572.93 | 284.14 | 235.75 | Upgrade
|
| Current Portion of Leases | 32.97 | 27.89 | 35.94 | 16.5 | 20.89 | Upgrade
|
| Current Income Taxes Payable | 989.29 | 1,443 | 68.69 | 936.81 | 1,116 | Upgrade
|
| Current Unearned Revenue | 1,833 | 1,971 | 2,432 | 2,368 | 1,051 | Upgrade
|
| Other Current Liabilities | 2,651 | 3,057 | 4,436 | 4,645 | 1,479 | Upgrade
|
| Total Current Liabilities | 15,134 | 14,933 | 14,565 | 12,909 | 8,330 | Upgrade
|
| Long-Term Leases | 335.14 | 145.76 | 116.04 | 45.42 | 32.71 | Upgrade
|
| Pension & Post-Retirement Benefits | 612.44 | 636.36 | 593.71 | 577.8 | 298.89 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 927.43 | 1,064 | 1,181 | 957 | 806.63 | Upgrade
|
| Total Liabilities | 17,009 | 16,779 | 16,455 | 14,489 | 9,469 | Upgrade
|
| Common Stock | 3,185 | 3,185 | 3,185 | 3,185 | 3,185 | Upgrade
|
| Retained Earnings | 29,363 | 23,965 | 17,364 | 16,742 | 16,675 | Upgrade
|
| Comprehensive Income & Other | 1,127 | 1,127 | 1,127 | 1,127 | 1,127 | Upgrade
|
| Shareholders' Equity | 33,675 | 28,277 | 21,676 | 21,053 | 20,987 | Upgrade
|
| Total Liabilities & Equity | 50,684 | 45,055 | 38,131 | 35,542 | 30,455 | Upgrade
|
| Total Debt | 614.63 | 372.28 | 724.9 | 346.07 | 289.36 | Upgrade
|
| Net Cash (Debt) | 7,978 | 6,141 | 2,886 | 4,408 | 8,429 | Upgrade
|
| Net Cash Growth | 29.90% | 112.80% | -34.54% | -47.70% | 48.37% | Upgrade
|
| Net Cash Per Share | 25.05 | 19.28 | 9.06 | 13.84 | 26.47 | Upgrade
|
| Filing Date Shares Outstanding | 318.47 | 318.47 | 318.47 | 318.47 | 318.47 | Upgrade
|
| Total Common Shares Outstanding | 318.47 | 318.47 | 318.47 | 318.47 | 318.47 | Upgrade
|
| Working Capital | 20,022 | 15,766 | 10,776 | 10,595 | 10,639 | Upgrade
|
| Book Value Per Share | 105.74 | 88.79 | 68.06 | 66.11 | 65.90 | Upgrade
|
| Tangible Book Value | 32,719 | 27,321 | 20,720 | 20,097 | 19,995 | Upgrade
|
| Tangible Book Value Per Share | 102.74 | 85.79 | 65.06 | 63.11 | 62.78 | Upgrade
|
| Land | 316.41 | 316.41 | 316.41 | 316.41 | 316.41 | Upgrade
|
| Buildings | 3,404 | 3,102 | 3,080 | 3,001 | 2,928 | Upgrade
|
| Machinery | 15,839 | 14,393 | 13,856 | 12,773 | 12,119 | Upgrade
|
| Construction In Progress | 3,333 | 3,087 | 1,295 | 1,236 | 1,178 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.